deferoxamine has been researched along with Auricular Fibrillation in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fabio, G | 1 |
Minonzio, F | 1 |
Delbini, P | 1 |
Bianchi, A | 1 |
Cappellini, MD | 1 |
Hehlmann, R | 1 |
Schmitz, H | 1 |
Krüger, K | 1 |
2 other studies available for deferoxamine and Auricular Fibrillation
Article | Year |
---|---|
Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH).
Topics: Adult; Amino Acid Substitution; Antimicrobial Cationic Peptides; Atrial Fibrillation; Chelation Ther | 2007 |
Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
Topics: Anemia, Aplastic; Atrial Fibrillation; Cardiomegaly; Deferoxamine; Female; Hemosiderosis; Humans; Ir | 1984 |